Faculty Information - KIKUCHI Noriko |

（Last updated : 2020-08-08 13:46:41）

KIKUCHI Noriko
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine

Position Assistant Professor

■ Published papers

1.	Original article	Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub-analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease. 2020/05
2.	Case report	An Autopsy Case of Arrhythmogenic Right Ventricular Cardiomyopathy　- Radiological/Pathological Comparison. 2020/04
3.	Original article	Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. 2019/06
4.	Original article	Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease. 2016/05
5.	Case report	Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. 2016/04
6.	Original article	Long-Term Prognostic Role of the Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/02
7.	Other	Pitavastatin Prevents Atherosclerotic Plaque Development via Inhibition of TRAIL Expression on CD4 T Cells 2010
8.	Other	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow up at a Tertiary Hospital in Japan 2010
9.	Other	Role of PSGL-1 Expressing CD4 T Cells in Acute Coronary Syndrome 2010
Display 5 items
Display all(9)

■ Academic conference presentation

1.	Factors Associated With Ejection Fraction Improvement Among Hospitalized Heart Failure Patients With Reduced Ejection Fraction 2019/11/17
2.	A case of chronic thromboembolic pulmonary hypertension in systemic sclerosis 2019/10/05
3.	A case with ischemic severe heart failure improved temporary after Autologous myoblast sheets transplantation therapy, but we could not save 2019/10/04
4.	Changes of ejection fraction among hospitalized heart failure patients: From HIJ-HFII study 2019/10/04
5.	Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study 2019/09/02
6.	Myocardial flow reserve using 13N ammonia PET for detection of cardiac allograft vasculopathy in heart transplant patients 2019/09/02
7.	Incidence and Predictors of Long-term Renal Function Deterioration after Implantation of a Centrifugal, Continuous-flow Device for Bridge to Transplant 2019/04/05
8.	Myocardial Flow Reserve Using 13N Ammonia PET for Detection of Cardiac Allograft Vasculopathy 2019/04/03
9.	Usefulness of Wearable Cardioverter Defibrillator as a Bridge Therapy 2019/03/31
10.	13N Ammonia PET Myocardial Flow Reserve for Detection of Cardiac Allograft Vasculopathy in Heart Transplant Patients 2019/03/30
11.	Management of Ventricular Arrhythmias in Patients with Implanted Ventricular Assist Devices 2019/03/30
12.	Prognostic Impact of Discharge Serum Chloride Levels in Heart Failure Patients: An Analysis of HIJ-HF II Multicenter Cohort Study 2019/03/30
13.	Renal Function and the Prognostic Impact of Renin-angiotensin-aldosterone System Inhibitors for Heart Failure Patients: An Analysis of HIJ-HF II Study 2019/03/29
14.	A new treatment option with ipragliflozin administered additionally in a caseinvolving stage D heart failure with diabetes 2018/10/13
15.	Treatment strategy for Cpc-PH after surgery of mitral valve disease; Insights from a case report 2018/10/13
16.	Cardiac Resynchronization Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia: Case Reports and Clinical Implications 2018/10/11
17.	Impact of congestion in worsening renal failure after implantation of a centrifugal, continuous-flow left ventricular device 2018/08/27
18.	Temporal trends in clinical characteristics, management of heart failure patients with mid-range ejection fraction in Japan: from the HIJ-HF studies 2018/05/26
19.	Use of mineralocorticoid receptor antagonists in real-world patients with nonischemic heart failure and reduced ejection fraction: an analysis of HIJ-HF II study 2018/05/26
20.	Long-Term Changes in Renal Function after Implantation of a Centrifugal-type, Continuous-flow Left Ventricular Assist Device 2018/03/25
21.	Use of Mineralocorticoid Receptor Antagonists in Real-world Heart Failure Patients with Reduced Ejection Fraction: An Analysis of HIJ-HF II Study 2018/03/25
22.	Heterozygous Familial Hypercholesterolemia: Insight into Polygenetic Abnormalities in Japanese Patients 2018/03/24
23.	Importance of physiological pacing on right heart failure in a case with left ventricular noncompaction and left ventricular assist device 2017/10/13
24.	Long-term changes in renal function in patients after implantation of a centrifugal-type, continuous-flow left ventricular assist device 2017/10/13
25.	Effectiveness of sildenafil for right ventricular failure after left ventricular assisted device implantation: a case report 2017/10/12
26.	Successful withdrawal of implantable left ventricular assist device in a case with major cerebrovascular complication 2017/10/12
27.	Short-term prevalence of fatal ventricular arrhythmic events in patients with newly diagnosed reduced left ventricular ejection fraction 2017/08/29
28.	Heart Team Approach for LVAD - Cooperation with Home Medical Care - 2017/03/19
29.	Recovery of Left Ventricular Ejection Fraction and Ventricular Arrhythmias in Heart Failure Patients: Prospects of Wearable Cardioverter Defibrillator 2017/03/19
30.	Adverse Effect of Underuse of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Therapy in Elderly Patients Hospitalized with Heart Failure 2017/03/18
31.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Japanese Heart Failure Patients: From the HIJ-HF Cohort Study 2017/03/18
32.	Prognostic Factors in Japanese Elderly Heart Failure with Preserved Ejection Fraction: From the HIJ-HF II Cohort Study 2017/03/17
33.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction 2017/03/17
34.	Beta-blockers and Prognosis in Patients with Atrial Fibrillation and Heart Failure: From the HIJ-HF Cohort 2016/10/09
35.	A Case of Dilated Cardiomyopathy Demonstrating Markedly Improvement from Deteriorated Renal Function by Challenging Catecholamine Infusion and Succeeding an Implantable-VAD 2016/10/08
36.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction 2016/10/08
37.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure with Preserved Ejection Fraction: From the HIJ-HF cohort study 2016/10/07
38.	The prognostic and therapeutic target role of atrial tachyarrhytmia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/07/16
39.	Prognostic Role of Atrial Tachyarrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasi 2016/03/19
40.	The Combination Therapy of Corticosteroid and Mycophenolate Mofetil in a Case of Refractory Cardiac Sarcoidosis 2015/10/22
41.	Prognostic Significance of Myocardial Fibrosis Detected by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 2015/04/26
42.	Atrial Arrhythmia is a Marker of Disease Progression in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2015/04/24
43.	Clinical Phases Vary with Disease Stage in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2015/04/24
44.	PSGL-1 expressing CD4 T cells in plaque instability 2011/08
45.	Impact of Pulmonary Artery Pressure and Transpulmonary gradient on Long-term Outcome in Dilated Cardiomyopathy Patients with Pulmonary Hypertension 2011/03/20
46.	Clinical Phases Vary with Time Course in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2011/03/19
47.	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow Up at a Tertiary Hospital in Japan 2011/03/19
48.	The Model for End-Stage Liver Disease Score as an Independent Predictor of Outcomes in Cardiac Resynchronization Therapy 2011/03/18
49.	The role of PSGL-1-expressing CD4 T cells in perimenopausal women 2010/07
Display 5 items
Display all(49)

■ Education

1.		Faculty of Medicine, Tokyo Women's Medical University, Graduated,
2.	Degree Acquisition	Tokyo Women's Medical University,